14 results · 19ms · Sources: EU EUDAMED, US FDA

Get notified when this changes

We'll email you when new records match this search — new devices, new clearances, certificate changes, or withdrawals.

EVER-SHARP BIOPSY FORCEPS

FDA 510(k)
FDA Class 1 ·Obstetrics/Gynecology

Snowden-Pencer

FDA UDI
STERIS CORPORATION·10885403278624·Snowden-Pencer MIS SWITCH-BLADE MINI METZENBAUM...

N/A

FDA UDI
STRYKER SUSTAINABILITY SOLUTIONS, INC.·00885825018009·Curved Mini Metzenbaum Scissor Tip

Arthrex®

FDA UDI
ARTHREX, INC.·00888867055131·PLATE, POW, LOCKING, TI, 3 MM

UNKNOWN V. MUELLER DEVICE

FDA Adverse Event
Injury ·CAREFUSION·Product code GEI·March 23, 2015

OPTI-TEARS(R)

FDA 510(k)
FDA Class 2 ·Ophthalmic

NON-STERILE PATIENT EXAMINATION GLOVES

FDA 510(k)
FDA Class 1 ·General Hospital

4.0MM TI LOCKING SCREW W/T25 STARDRIVE 20MM F/IM NAILS-STER

FDA Adverse Event
Malfunction ·SYNTHES MONUMENT·Product code HSB·January 23, 2014

G4 PLATINUM CONTINUOUS GLUCOSE MONITORING SYSTEM

FDA Adverse Event
Malfunction ·DEXCOM, INC.·Product code MDS·June 25, 2014

VENT TUBE 1016010 5PK GOODE T 1.14X12MM

FDA Adverse Event
Injury ·XOMED MFG JACKSONVILLE·Product code ETD·January 3, 2013

INTERSTIM

FDA Adverse Event
Injury ·MEDTORNIC NEUROMODULATION·Product code EZW·November 8, 2010

SWITCH-BLADE CLICKFIT REUSE HNDL 5MM36CM

FDA Adverse Event
Malfunction ·CAREFUSION·Product code GEI·October 5, 2011

Pipeline Flex Embolization Device

FDA Enforcement
Class I ·Ongoing·Micro Therapeutics Inc,·September 15, 2021

Assurity Model Numbers: PM1240, PM2240; Assurity + Model Number: PM2260; Accent Model Numbers: PM1210, PM2210, PM1222, PM2212; Accent MRI Model Numbers: PM1224, PM2218, PM2224 Implantation of a single-chamber pulse generator, dual-chamber pulse generator, or CRT-P is indicated in one or more of the following permanent conditions: Syncope, Presyncope, Fatigue, Disorientation, Or any combination of those symptoms. Implantation of a CRT-P is indicated for: Maintaining synchrony of the left and right ventricles in patients who have undergone an AV nodal ablation for chronic atrial fibrillation and have NYHA Class II or III heart failure. The reduction of the symptoms of moderate to severe heart failure (NYHA Class III or IV) in those patients who remain symptomatic despite stable, optimal medical therapy, and have a left ventricular ejection fraction d35% and a prolonged QRS duration

FDA Enforcement
Class II ·Terminated·St Jude Medical Inc.·October 25, 2017